SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

India Rating & Research affirms Claris Lifesciences’ Long Term issuer rating at ‘A-’

03 Apr 2013 Evaluate

Credit rating agency, India Rating & Research has affirmed India - based Claris Lifesciences’ Long Term issuer rating at ‘A-’ on Rating Watch Positive (RWP). This reflects the significant improvement in the company’s Credit profile and improvement in credit metrics.

Claris Lifesciences has recently received the long awaited USFDA approval for its manufacturing facility. The company now has nine ANDAs approved in its name across four molecules. The company has a total filing of 30 ANDAs across 20 products.

Peers
Company Name CMP
Redington 280.90
Amrapali Industries 42.31
Adani Enterprises 3037.90
Rashi Peripheral 752.80
PDS 338.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: